Product Information
ESCITALOPRAM 20 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0639 per EA under NDC 16571075710. Its NADAC has been published 142 times since Oct 11, 2023.
Strength
20 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571075710
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA078777On Market Since
6/10/2023
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 20 MG TABLET has been published 142 times since Oct 11, 2023, and over the history we have for it it has declined 24.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0639 per EA |
|---|---|
| All-time high | $0.0892 (Feb 14, 2024) |
| All-time low | $0.0548 (Nov 20, 2024) |
| 52-week high | $0.0766 |
| 52-week low | $0.0605 |
| Median price | $0.0732 |
| Average price | $0.0724 |
| Largest weekly change | -29.2% (Nov 20, 2024) |
| Weeks tracked | 142 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 20 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0639 per EA (NDC 16571075710), effective Jun 24, 2026.
How has the price of ESCITALOPRAM 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 20 MG TABLET has declined 24.2%. It has been tracked across 142 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 20 MG TABLET?
Since Oct 11, 2023, the NADAC for ESCITALOPRAM 20 MG TABLET has ranged from a low of $0.0548 (Nov 20, 2024) to a high of $0.0892 (Feb 14, 2024), with a median of $0.0732 per EA.
Are there cheaper alternatives to ESCITALOPRAM 20 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as ESCITALOPRAM 20 MG TABLET, but none are currently priced below it.
Who manufactures ESCITALOPRAM 20 MG TABLET?
ESCITALOPRAM 20 MG TABLET (NDC 16571075710) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification